- Report
- November 2026
- 168 Pages
Global
From €5430EUR$5,850USD£4,529GBP
- Report
- July 2026
- 160 Pages
Global
From €3082EUR$3,320USD£2,571GBP
€3852EUR$4,150USD£3,213GBP
- Report
- February 2026
- 250 Pages
Global
From €4168EUR$4,490USD£3,476GBP
- Report
- September 2026
- 181 Pages
Global
From €3291EUR$3,545USD£2,745GBP
€3656EUR$3,939USD£3,050GBP
- Report
- June 2026
- 180 Pages
Global
From €4409EUR$4,750USD£3,678GBP
- Report
- July 2024
- 120 Pages
Global
From €5523EUR$5,950USD£4,607GBP
- Report
- April 2023
- 119 Pages
Global
From €4177EUR$4,500USD£3,484GBP
- Report
- November 2025
- 132 Pages
Global
From €882EUR$950USD£736GBP
The Peptide Microarray market is a subset of the biotechnology industry that focuses on the development and production of peptide microarrays. These microarrays are used to detect and measure the presence of peptides in a sample, and are used in a variety of research and clinical applications. Peptide microarrays are used to identify biomarkers, measure drug efficacy, and study protein-protein interactions. They are also used to study the effects of post-translational modifications on protein function.
The Peptide Microarray market is highly competitive, with a number of companies offering products and services. Companies in the market include Agilent Technologies, Bio-Rad Laboratories, Merck Millipore, PerkinElmer, and Thermo Fisher Scientific. Show Less Read more
